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GUIDELINES
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The “3 Hour” Bundle
Introduction
Sepsis is the leading cause of morbidity and mortality. It is
estimated that 60-80% of deaths in low and in low to middle
income countries occurs due to sepsis.1,2  Data from Pakistan
is scanty. Sepsis accounts for about 1.3% of all admissions at
the Aga Khan University Hospital, Karachi, Pakistan, and has
mortality approaching 37%, which is significantly associated
with the presence of septic shock.3
With the publication of both the Protocol Based Care for Early
Septic Shock (ProCESS) and the Australasian Resuscitation in
Sepsis Evaluation (ARISE) trials in 2014, the importance of
adherence to the 3 Hour Bundle of initial sepsis management
to significantly impact on the morbidity and mortality of patients
along the sepsis spectrum, was recognized.4,5,6
Severe sepsis and septic shock can be managed effectively
using our locally-adapted sepsis guidelines, which delineate
simple interventions to be instituted in a timely manner. This
is expected to have a significant impact on sepsis outcomes in
our patients.
The 3 Hour Bundle Management Protocol (Appendix 1)
There are 4 main components to the 3 Hour Bundle. These are:
1. Early recognition of Sepsis/Severe Sepsis/Septic Shock
2. Diagnostic work up
3. Antibiotic administration
4. Fluid and vasopressor management
Early Recognition
Early recognition of the patient presenting along the sepsis
spectrum remains critical to the effective early implementation
of the 3 Hour Bundle. Two main areas to the successful
development of early recognition are education and the use of
screening tools.
1. Education
Education remains a cornerstone in the successful
implementation of guidelines into practice. It is hoped that with
the development and acceptance of these guidelines a local,
provincial and national dialogue can be started as to how to
collect the necessary epidemiological data for sepsis as well as
as well as plan for dissemination of these guidelines to the
healthcare professionals and our patients
2. Screening Tools
The use of a screening tool can both help educate and provide
rapid identification of the patient with sepsis by first responders
such as: ER Triage nurses and physicians, Rapid Response and
Cardiac Arrest Teams, and the bedside and/or OPD nurse and
physician. An example of a sepsis screening tool is provided
in Appendix 2.
Diagnostic Work Up
When possible a complete diagnostic panel for patients with
sepsis should be sent including:
Complete blood count and Platelets
Basic Electrolytes (Sodium, Potassium, Chloride,
Bicarbonate, Glucose, Bun and Creatinine)
PT/PTT and INR
Urine DR
Cultures: Blood, Urine and Sputum
Lactic Acid
Radiological studies (x-rays, ultrasound, CT scans) should be
ordered guided by the history and physical exam. If an infective
source is identified that is amenable to surgical correction a
surgical consult should be called early for appropriate source
control.
Special Consideration of the following is recommended:
Blood Cultures. Please see Appendix 3 for proper sampling
and handling of blood cultures
Biomarkers of Sepsis: Biomarkers of sepsis such as ESR
and CRP have no role in the diagnosis, prognostication
and/or therapy guidance of sepsis. At present only
Procalcitonin has any significant sensitivity and specificity
for diagnosis, prognostication and therapy guidance for
sepsis. Having said that the sensitivity and specificity for
any of the above tests (including Procalcitonin) remains
less than optimal and therefore its routine use in sepsis
cannot be recommended.7,8
Lactate: The last decade has seen resurgence in the
diagnostic, prognostic and therapeutic guidance of lactate
for the patient with sepsis, severe sepsis septic shock.9,10,11,12
It is important to emphasize that the patient who meets the
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definition of sepsis and yet has no other signs, symptoms
or laboratory evidence suggestive of severe sepsis can still
meet the new operational definition of severe sepsis with
an isolated lactate of 4 mmol/L or higher (Glossary of
Terms).
Base Deficit: In view of the resource limitations to
healthcare delivery in Pakistan it is understood that a blood
lactate test may not be available. It is therefore suggested
that the base deficit in an arterial blood gas sample may be
used to detect acidosis in the patient with sepsis.13, 14 This
recommendation is made with the following caveats:
o To date there has been no study to evaluate the utility of
base deficit in lieu of a serum lactate for the diagnosis of
severe sepsis or as a marker for resuscitation in severe
sepsis/septic shock.
o Base deficit cannot be used as a surrogate marker for lactate
if there is hyperchloremic acidosis from normal saline
administration, renal failure or diabetic ketoacidosis.
o Given the varied reasons for an elevated base deficit, it is
has limitations as an endpoint of resuscitation for sepsis.
Antibiotics
The importance of early and appropriate antibiotic administration
cannot be overemphasized in in managing sepsis. The study by
Kumar et al demonstrated that for every hour delay in
administration of antibiotics to the patient with sepsis induced
hypotension or shock resulted in 12% decreased probability of
survival.15
The factors which are clearly associated with sepsis outcomes
include the site of infection, the kind of organisms involved
and their susceptibility patterns, time to diagnosis and institution
of fluid resuscitation and the types of antibiotics selected for
empiric and definitive treatment.
Our local data shows that among enterobacteriaceae (E.coli,
klebsiella, enterobacter) resistance patterns are as follows:
3rd generation cephalosporins currently ranges from 50-80%,
ciprofloxacin 30-70%, piperacillin-tazobactam 20-30% and
carbapenems between 2-15% .16
Of special consideration is the fact that carbapenem resistance
enterobacteriaceae (CRE) is associated with a high sepsis-
related mortality of up to 80%.17 The numbers of deaths are 2-
fold higher among patients with bacteremia caused by CRE as
compared with carbapenem-sensitive enterobacteriaceae (CSE).18
In our context, mortality secondary to bacteremia caused by
carbapenem- resistant gram negatives (including
CRE,acinetobacter and pseudomonas) has been 54% vs 36%
due to sensitive organisms. With additional resistance to 3rd
generation cephalosporins and ciprofloxacin the mortality
approaches 90% .19
Please see Appendix 5 for details.
Intravenous Fluids and Vasopressors:
Intravenous Access:
The following is suggested:
o Initial IV access for sepsis should be an upper extremity
peripheral line
o Initial IV access for severe sepsis and septic shock should
be either single or two upper extremity peripheral lines of
18 gauge or larger when possible.
Pedal peripheral IV access (foot IVs) should be avoided because
of the increase in transit time from the foot to the central
circulation that can result from vasoconstriction from hypotension,
shock, and/ or the administration of vasopressors.20, 21
Type of fluid for resuscitation:
o For sepsis there is no recommendation for routine fluid
administration.
o For severe sepsis and septic shock crystalloids (Normal
saline or Ringers Lactate) are recommended over colloids.9, 22
Dose and method of fluid administration for severe sepsis
and septic shock.10, 23, 24
o In the 3 Hour bundle fluid is administered to a total dose
of 30cc/kg.
o Crystalloid is administered as a fluid bolus
250 cc over 10 minutes
500 cc over 15 minutes
1000 cc over 30 minutes
o Administer as follows:
10 ml/kg over 15-30 minutes
If a systolic blood pressure of 90mmHg or greater or a
Mean Arterial Pressure of 65 mmHg or greater is not
reached after the above bolus then repeat 5ml/kg over 15
minutes and repeat every 15 minutes until the above blood
pressure goal is reached or a total of 30 cc/kg administered.
Vasopressors
o If vasopressors are used to support the blood pressure while
the fluid boluses are given or after the 30ml/kg total dose
is given and the patient is still in shock the following is
recommended.9, 25
Norepinephrine is the first line vasopressor for use in septic
shock
Dopamine may be used in place of Norepinephrine if
Norepinephrine is not available
If the maximum dose of Norepinephrine or Dopamine is
reached, and the patient is still in shock, then Epinephrine
can be added.
Vasopressin in doses of 0.03-0.04 units/min can be added
to norepinephrine to help attain the above blood pressure
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targets or to reduce the dose of norepinephrine being given.
Recommendations for implementation and monitoring of
the 3 Hour Bundle
Order sets provide a method of funneling the decision
matrix of the bedside provider along best practice
recommendations.26 An example of an order set modified
and developed at the Aga Khan University Hospital (AKUH)
Karachi Pakistan is presented in the appendix section of
this document (Appendix 4). The addition of a carbon back
to the order set allows easy storage and later abstraction
of data for monitoring of compliance with the bundle
elements.
When following compliance of the 3 hour bundle in an
emergency room, time zero is when the patient presents to
triage.
An algorithm for the 3 hour bundle, modified and developed
at the AKUH Karachi Pakistan is presented in Appendix 1.
Following an institution’s lactate test volume and volume
of norepinephrine units used can help an organization




A set of evidence based diagnostic and therapeutic interventions
(usually 3-5 elements) that together can help improve patient
outcomes.27
2. Systemic Inflammatory response (SIRS)28 2 or more of
the following:
a. Temp>38 or <36
b. Heart rate >90 beats/min
c. Resp rate >20 breaths/min
d.  WBC >12,000 or <4,000 or 10% bands
3. Sepsis28
SIRS + Infection (known or suspected source) = Sepsis
4. Severe Sepsis28
Sepsis criteria + evidence of organ dysfunction or Sepsis
criteria + Lactate >/ 4mmol/L
Cardiovascular: Systolic BP ≤90 mmHg, MAP ≤70 mm
Hg for at least 1 hour despite volume resuscitation, or the
use of vasopressors.
Renal: Urine output < 0.5 ml/kg body weight/hr for 1 hour
despite volume resuscitation. Creatinine > 2.0 mg/dL
Pulmonary: PaO2/FiO2 ≤250 if other organ dysfunction
present or ≤ 200 if the lung is the only dysfunctional organ.
Hematologic: Platelet count ≤100K or decreased by 50%
in 3 days
Metabolic: pH ≤ 7.3 and plasma lactate > 4
Altered Mental Status
Bilirubin > 2mg/dL
5.  Septic Shock10
Persistent arterial hypotension despite adequate volume
resuscitation
6. Hypotension10
Systolic blood pressure of <90 mmHg, or a mean arterial
pressure (MAP) < 65 mmHg, or a decrease of >/ 40mmHg in
the systolic blood pressure from baseline
7. Shock10
Life threatening, generalized form of circulatory failure
associated with inadequate oxygen utilization by the cells
resulting in cellular dysoxia
( See appendex 1 to 5 from next page.)
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Appendix 1
Start Antibiotics (Refer to Hospital Antibiogram)
Recognize Severe Sepsis. FILL OUT SEPSIS ORDER SET
ADVANCE RESUSCITATION : CALL EXPERT CONSULTATION
SIRS criteria
• Temp>38°C or <36°C
• Heart rate >90 beats/min
• Resp rate >20 breaths/min
• WBC >12,000 or <4,000 or 10% bands
SIRS + Infection = SEPSIS
Sepsis criteria + evidence of organ dysfunction or Sepsis criteria + Lactate 4mmol/L
• CV: Systolic BP ≤90 mmHg, MAP ≤70 mm Hg for at least 1 hour despite volume resuscitation,
or the use of vasopressors.
• Renal: Urine output < 0.5 ml/kg body weight/hr for 1 hour despite volume resuscitation
• Pulmonary: PaO2/FiO2 ≤250 if other organ dysfunction present or ≤200 if the lung is the only dysfunctional organ.
• Hematologic: Platelet count ≤100K or decreased by 50% in 3days
• Metabolic: pH ≤7.3 and plasma lactate > 4 mmol/L
• Altered Mental Status
SEVERE SEPSIS
Cultures + Lactate, CBC, Basic Metabolic panel PT/PTT INR, LFTs, Urine DR
Radiology: CxR and others
Early Surgical Consultation is recommended if the above work up suggests a surgical amenable focus of infection
If MAP <65 mmHg and/or Lactate > 4mmol/L and/or signs/labs of organ dysfunction START IVF Crystalloid
(10 ml/kg) over 15-30 minutes THEN If BP goal not attained give 5ml/kg every 15 minutes up to 30 ml/kg
PATIENT REMAINS WITH MAP < 65 mmHg AFTER I L of FLUID START
NOREPINEPHRINE AT 0.01 µg/kg/min and titrate to MAP 65 mmHg. CONTINUE FLUID RESUSCITATION
UNTIL TOTAL 30cc/kg/ given
Insert Central Venous Access at 3 hours if patient still in shock and titrate Norepinephrine to obtain a MAP >/ 65 mmHg.
IF PATIENT IN SHOCK AFTER 3 HOURS OR REPEAT LACTATE 4 mmol/L at 3 HOURS THEN:
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Evaluation for Severe Sepsis Screening Tool
Appendix 2
Instructions: Use this optional tool to screen patients for severe sepsis in the emergency department, on the
medical/surgical floors, or in the ICU.
1. Is the patient’s history suggestive of a new infection?
Pneumonia, empyema Bone/joint infection Implantable device infection
Urinary tract infection Wound infection Other infection
Acute abdominal infection Blood stream catheter infection
Meningitis Endocarditis
Skin/soft tissue infection Yes No
2. Are any two of following signs & symptoms of infection both present and new to the patient? Note: laboratory
values may have been obtained for inpatients but may not be available for outpatients.
Hyperthermia > 38.3 °C (101.0 °F) Tachypnea > 20 bpm Hyperglycemia (plasma glucose
Hypothermia < 36 °C (96.8°F) Leukocytosis (WBC count >12,000 µL–1) >140 mg/dL) or 7.7 mmol/L in
Altered mental status Leukopenia (WBC count < 4000 µL–1) the absence of diabetes
Tachycardia > 90 bpm
If the answer is yes, to both questions 1 and 2, suspicion of infection is present:
Obtain: lactic acid, blood cultures, CBC with differential, basic chemistry labs, bilirubin.
At the physician’s discretion obtain: UA, chest x-ray, amylase, lipase, ABG, CT scan.
 Yes  No
3. Are any of the following organ dysfunction criteria present at a site remote from the site of the infection that are
NOT considered to be chronic conditions? Note: in the case of bilateral pulmonary infiltrates the remote site stipulation
is waived.
SBP < 90 mmHg or MAP <65 mmHg
SBP decrease > 40 mm Hg from baseline
Creatinine > 2.0 mg/dl (176.8 mmol/L) or urine output < 0.5 ml/kg/hour for 2 hours Bilirubin > 2 mg/dl (34.2 mmol/L)
Platelet count < 100,000 µL Lactate > 2 mmol/L (18.0 mg/dl)
Coagulopathy (INR >1.5 or aPTT >60 secs)
Acute lung injury with PaO2/FiO2 <250 in the absence of pneumonia as infection source
Acute lung injury with PaO2/FiO2 <200 in the presence of pneumonia as infection source
Yes No
If suspicion of infection is present AND organ dysfunction is present, the patient meets the criteria for SEVERE
SEPSIS and should be entered into the severe sepsis protocol.
Date: _/ / (circle: dd/mm/yy or mm/dd/yy) Time: _: (24 hr. clock)
Version 7.2.13
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Appendix 3
Technique for Proper Blood Culture Sampling
1. Gather necessary equipment: 20 ml syringe, 2 aerobic
and 2 anaerobic bottles for 2 sets of blood cultures, skin
prep swabs, tourniquet, sharps disposal box, gloves.
                                     
2. Verify the patient's identification and explain procedure
3. Wash or sanitize hands before and after removing gloves.
Follow Standard Precautions for all patients. Wear clean
gloves.
                              
Masks with face shields may be worn for drawing blood
cultures depending on the clinical situation.
4. Assemble necessary equipment before preparation of the
patient's skin.
1. Remove dust caps from culture bottles.
2. Clean surface with alcohol wipe.
3. Leave the alcohol wipe on the bottle top during skin
preparation.
5. Remove alcohol wipe just prior to inoculating the bottles
- do not use iodine.
6. Apply tourniquet to the extremity and identify the
phlebotomy site.
7. Preparation of the phlebotomy site: clean site with
chloraprep or 70% isopropyl alcohol for 30 seconds
prior to chlorhexidene or povidone iodine (if chorhexidene
is not available,inferior)
                  
1. Using chloraprep, use a firm scrubbing motion for
30 seconds over a 5 cm area of the skin using circular
motion starting at the site and working outward.
2. Allow 30 seconds for drying before venipuncture.
3. Using sequential chlorhexidene or povidone iodine,
cleanse a 5 cm area using circular motion starting
at the site and working outward.
4. Allow to dry for a at least 30 seconds to allow
antiseptic effect
5. Clean patient's skin with alcohol to remove excess
iodine (to prevent iodine burns).
If unable to use either of the above
a) Use alcohol to cleanse the patient's skin, using a
circular motion starting at the site and moving
outward.
b) Repeat times two.
c) Allow to dry.
6. Do not touch the venipuncture site after skin
preparation. If palpation is absolutely necessary,
sterile gloves must be applied immediately prior to
palpation.
7. Insert needle into vein and withdraw 20 ml of blood.
Do not collect blood through IV cannula even it is
freshly inserted.
8. Inject 10 ml of blood into each culture bottle. Needles
should not be changed before inoculating culture medium.
9. If an inadequate amount of blood was obtained (less
than 5 ml), and repeat phlebotomy cannot be performed;
all blood should be preferentially inoculated in the
aerobic culture bottle.
10. Label culture bottles with patient's name and MR number.
11. Fill out Microbiology lab slip.
1. Indicate site from which blood was collected using
comment section. If using aVascular Access Device
(VAD) to draw culture, you must indicate type and
site of VAD in the comments section (i.e., left
subclavian triple lumen).
2. Indicate suspected diagnosis, if necessary (required
for R/O endocarditis).
3. Include date and time of collection.
4. Document that cultures were obtained on appropriate
form
12. Send specimens to the laboratory as soon as possible.
Do not refrigerate blood culture specimens.
Contd. on next page
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13. Send second set of blood cultures using the same
procedure as above. If a different peripheral site is
possible, the second set may be drawn immediately. If
using the same site, wait at least 10 minutes for the
second set, and if possible (i.e. not waiting to give
antibiotics) draw second set 1-3 hours later.
Biosafety Considerations:
Discard used syringes in the sharps bin; used gloves and
swabs should be discarded as controlled medical waste.
14. In order to rule out diagnoses, more specific blood
culture procedures may be necessary.
1. Suspected catheter sepsis
1. Draw two culture sets, using a fresh syringe
for every venipuncture/draw
2. One set is obtained from a suspected site.
3. Second set must be from a separate peripheral site.
4. If catheter is removed, send tip (3 cm) using
sterile procedure for cultures. Do not send
catheter tipwithout sending concomitant
blood cultures.
2. Acute endocarditis
1. Draw two culture sets from two separate sites
during the first 1-2 hours of evaluation.
2. Begin therapy.
3. Subacute endocarditis
1. Draw 2-3 blood culture sets on day 1.
2. If all are negative additional sets can be drawn
on days 2 and 3 (no more than 4 sets in a 24
hour period).
3. Immediate antibiotics are less important than
establishing a specific microbial diagnosis.
4. Endocarditis patients on anti-microbial therapy
1. Draw resin blood culture sets on each of three
successive days.
2. Indicate "R/O endocarditis" in special
instructions on lab requisition.
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Appendix 4 Patient Identification & Location
PHYSICIANS’ ORDERS
ADULT SEPSIS ORDER SET PAGE 1 of 3
Note: Check Box Where Appropriate
PLEASE WRITE ALL ‘MEDICATION AND IV FLUID’ ORDERS ON THE SEPARATE SHEET,
DESIGNED FOR THE PURPOSE
RN SIGNATURE - TIMEDATE AND TIME ORDER, SIGNATURE AND TITLE




Sepsis Severe Sepsis Septic Shock





Vital Signs every 15 minutes X 1 hour, then per unit policy
Strict Intake and Output
Activity: Bed Rest Other
Diet: NPO Other
LABS:
Sepsis Panel (IF CHECKED SEND ENTIRE LABS BELOW)
: CBC with Differential and Platelet Count
: PT/PTT
: BUN/Creatinine
: Serum Electrolytes (Na, K, Cl, HCO3, BUN, Creatinine)
: Lactic Acid and Repeat every 6 hours for next 24 Hours
: Urine DR
: Procalcitonin
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Patient Identification & LocationPHYSICIANS’ ORDERS
ADULT SEPSIS ORDER SET PAGE 2 of 3
Note: Check Box Where Appropriate
PLEASE WRITE ALL ‘MEDICATION AND IV FLUID’ ORDERS ON THE SEPARATE SHEET,
DESIGNED FOR THE PURPOSE
RN SIGNATURE - TIMEDATE AND TIME ORDER, SIGNATURE AND TITLE
DVT Prophylaxsis:
ANTIBIOTICS: ADJUST FOR RENAL and/or HEPATIC DYSFUNCTION
SEPSIS SOURCE UNKNOWN:
Piperacillin-Tazobactum 3.375gm Q6 Hours IV
OR
Imipenem Cilastatin 500mg Q8 Hours   IV
OR
Cefoperazone Sulbactam 400mg  Q12 Hours IV
And Clindamycin 600mg  Q8 Hours  IV
IF MRSA SUSPECTED THEN ADD
Vancomycin:Load 20mg/kg IV
Maintenance  15mg/kg  Q 12 Hours IV
SUSPECTED
Piperacillin-Tazobactum 3.375gm Q6 Hours IV
And Levofloxacin 500mgQ24 Hours IV
Ceftriaxone 2gm  Q24 Hours IV
And Levofloxacin 500mg  Q24 Hours IV
OR
SUSPECTED SKIN & SOFT TISSUE INFECTION:
Cefazolin 2gm Q8 Hours IV
IF Penicillin Allergic
Clindamycin 600mg  Q8 Hours  IV
And
Ciprofloxacin 400mg  Q12 Hours IV
IF MRSA SUSPECTED THEN ADD
Vancomycin: Load 20mg/kg IV
Maintenance  15mg/kg Q 12 Hours IV
SUSPECTED ABDOMINAL INFECTION:
Piperacillin-Tazobactum 3.375gm Q6 Hours    IV
OR
Imipenem Cilastatin 1 gm  Q8 Hours   IV
OR
Ceftriaxone 2gm  Q24 Hours  IV
And Amikacin 15mg/kg  Q24 Hours IV
And Metronidazole 500mg    Q8 Hours   IV
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IF AFTER RECEIVING FLUID BOLUS 30ml/kg PATIENT STILL
IN SHOCK AND/OR REPEAT LACTATE 4 OR GREATER OBTAIN
URGENT EXPERT CONSULTATION
Patient Identification & LocationPHYSICIANS’ ORDERS
ADULT SEPSIS ORDER SET PAGE 3 of 3
Note: Check Box Where Appropriate
PLEASE WRITE ALL ‘MEDICATION AND IV FLUID’ ORDERS ON THE SEPARATE SHEET,
DESIGNED FOR THE PURPOSE
RN SIGNATURE - TIMEDATE AND TIME ORDER, SIGNATURE AND TITLE
SUSPECTED UROSEPSIS
Piperacillin-Tazobactum 3.375gm Q6 Hours IV
OR
Imipenem Cilastatin 500mg Q8 Hours IV
IF RISK OF ENTEROCCOCUS
Vancomycin: Load 20mg/kg IV
Maintenance  15mg/kg Q 12 Hours IV
SUSPECTED CNS INFECTION
Ceftriaxone 2gm  Q24 Hours IV
AND
Vancomycin:  Load 20mg/kg IV
Maintenance 15mg/kg Q 12 Hours IV
OR
Meropenem 2gm  Q8 Hours IV
SUSPECTED HOSPITAL ACQUIRED INFECTION
Piperacillin-Tazobactum 3.375gm Q6 Hours IV
AND  Vancomycin:  Load 20mg/kg IV
Maintenance 15mg/kg Q 12 Hours IV
OR
Imipenem Cilastatin 500mg Q8 Hours   IV
AND  Vancomycin:  Load 20mg/kg IV
Maintenance  15mg/kg Q 12 Hours IV
AND Colistin 9MU stat  and 3MU Q 8hours IV
See appendix 5 for details
FOR PATIENTS WITH SYSTOLIC BLOOD PRESSURE LESS THAN 90 mmHg
Initial intravenous fluids per kg estimated ideal body weight
Target BP greater than 90 mmHg systolic and Mean Arterial Pressure
(MAP) greater than 65 mmHg
Normal saline (10 ml/kg)            ml over 15-30 minutes THEN
If BP goal not attained 5ml/kg every 15 minutes up to 30 ml/kg
Ringers Lactate (10 ml/kg) ml over 13-30 minutes THEN
If BP goal not attained 5ml/kg every 15 minutes up to 30 ml/kg
VASOPRESSOR (Titrate to systolic BP greater than 90 mmHg and
MAP greater than 65 mmHg
Norepinephrine         mg in            ml D5W at         micrograms/min
Continuous Infusion
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Before Selecting Empirical therapy
Appendix 5 Antibiotics in Sepsis
• Selection of antibiotic must be based on clinical assessment of site of infection
• Viremia, severe malaria or fungemia must be considered as possible causes of sepsis
• Antibiotics must be administered as soon as possible, within 2 hours of admission to ER or ICU
• Two sets of blood cultures, urine analysis and urine culture must be drawn prior to institution of antibiotic
• Obtain history of previous use of antibiotics in past 3 months. Avoid same antibiotic if possible
• Dose must be prescribed on weight basis
• Dose must be adjusted for renal or hepatic insufficiency, diabetes
• Hematologic malignancy or febrile neutropenia must be considered
• Combination therapy and use of colistin may be considered for suspected highly resistant pathogens, e.g sepsis
 in patients with pro-longed hospital or ICU stay, transfer from another healthcare facility, immunocompromised status.
• Only intravenous antibiotic should be used until there is clinical improvement
• Empiric antifungal therapy may be considered initially in specific circumstances, e.g. perforated viscus or prolonged
antibacterial therapy in immunocompromised patients
During antibiotic therapy
• Once culture and sensitivity reports are available, de-escalate to a narrower spectrum antibiotic
• Once patient shows clinical improvement and is stable, de-escalate to oral preparation, if an equally effective oral
preparation is available
• Antibiotic should be given for no longer than 7-10 days
• Source control is essential, i.e. drainage of abscess, repair or resection of perforated viscus, removal of cannula, catheter,
devices, debridement of infected tissue.
Table 1
Best empirical antibioticSource of infection Likely pathogen
Urinary tract E. coli Carbapenem or Piperacillin –tazobactam or
Cefaperazone-sulbactam
Genital tract E. coli, Enterococcus, S hemolyticus, Carbapenem or Piperacillin –tazobactam or
Anaerobes Cefaperazone-sulbactam + vancomycin
Respiratory tract (CAP) S. pneumoniae, atypical Ceftriaxone +levofloxacin or clarithromycin
Respiratory tract (HAP) GPC, GNR, atypical Carbapenem or Piperacillin –tazobactam or
Cefaperazone-sulbactam + levofloxacin or 
clarithromycin
Respiratory tract (VAP) GNR, MRSA Carbapenem or Piperacillin –tazobactam
+ Colistin (colistimethate sodium)9MU stat  and
3MU Q 8hours IV  or
Cefaperazone-sulbactam + vancomycin+ Colistin
9MU stat and 3MU Q 8hours IV
Intra-abdominal Gram negatives, anerobes Carbapenem or Piperacillin –tazobactam or
Cefaperazone-sulbactam + vancomycin
SSTI (necrotizing fasciitis) S. aureus, Streptococci anerobes Amoxicilin/clavulanate or clindamycin
+vancomycin
Burn sepsis S. aureus, Streptococci, Pseudomonas, Carbapenem or Piperacillin –tazobactam or
Candida Cefaperazone-sulbactam + vancomycin
Line sepsis S. aureus, (MSSA, MRSA), Pseudomonas Ceftazidime  or amikacin+ vancomycin
Infected device S. aureus, (MSSA, MRSA), Pseudomonas Ceftazidime  or amikacin+ vancomycin
Bacterial meningitis S pneumoniae, Meningococcus Ceftriaxone + vancomycin + steroid
Volume 24 Issue 01 Jan - Mar 2015.  795
References
1. www.pjcm.net/Data/Year2013/pdf_v19_n2_a5.pdf Last accessed Feb 23
2015
2. Kissoon N, et al. World Federation of Pediatric Intensive Care and Critical
Care Societies: Global Sepsis Initiative. Pediatr Crit Care Med. 2011;12(5):
494-503.
3. Siddiqui S, Jamil B, Nasir N, Talat N, Khan FA, Frossard P, Hussain R.
Characteristics and outcome of sepsis - A perspective from a tertiary care
hospital in Pakistan. International Journal of Scientific & Engineering
Research 2013; Volume 4(9):1013-1023
4. The ProCESS Investigators. A randomized trial of protocol-based care
for early septic shock. N Engl J Med 2014;370:1683-93
5. The ARISE Investigators and the ANZICS Clinical Trial Group. Goal
Directed Resuscitation for Patients with Early Septic Shock. N Eng J
Med 2014;371:1496-506
6. Lilly CM. The ProCESS Trial-A New Era of Sepsis Management. N Engl
J Med 2014;370;1750-1751
7. Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin
and C-reactive protein levels as markers of bacterial infection: a systematic
review and meta-analysis. Clinical infectious diseases. 2004;39(2):206-17
8. Riedel S. Procalcitonin and the role of biomarkers in the diagnosis and
management of sepsis Diagnostic Microbiology and Infectious Disease
2012; 73: 221-227
9. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM,
et al. Surviving Sepsis Campaign: international guidelines for management
of severe sepsis and septic shock, 2012. Intensive care medicine.
2013;39(2):165-228.
10. Cecconi M, De Backer D, Antonelli M, Beale R, Bakker J, Hofer
C, et al. Consensus on circulatory shock and hemodynamic monitoring.
Task force of the European Society of Intensive Care Medicine. Intensive
care medicine. 2014;40(12):1795-815.
11. Nguyen HB, Kuan WS, Batech M, Shrikhande P, Mahadevan M, Li C
H, et al. Outcome effectiveness of the severe sepsis resuscitation bundle
with addition of lactate clearance as a bundle item: a multi-national
evaluation. Crit Care. 2011;15(5):R229.
12. Casserly B, Phillips GS, Schorr C, Dellinger RP, Townsend SR, Osborn
TM, et al. Lactate measurements in sepsis-induced tissue hypoperfusion:
results from the surviving sepsis campaign database*. Critical care
medicine. 2015;43(3):567-73.
13. Englehart MS, Schreiber MA. Measurement of acid-base resuscitation
endpoints: lactate, base deficit, bicarbonate, or what? Curr Opin Crit Care
2006; 12:569-574
14. Mutschler M, Nienaber U, Brockamp T, Wafaisade A, Fabian T, Paffrath
T, et al. Renaissance of base deficit for the initial assessment of trauma
patients: a base deficit-based classification for hypovolemic shock
developed on data from 16,305 patients derived from the TraumaRegister
DGUÂ®. Crit Care. 2013;17(2):R42.
15. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al.
Duration of hypotension before initiation of effective antimicrobial therapy
is the critical determinant of survival in human septic shock*. Critical
care medicine. 2006;34(6):1589-96.
16. http://www.parn.org.pk/index_files/MULTI.RESISTANT.html Last
accessed Feb 23, 2015
17. Falagas ME, Lourida P, Poulikakos P, Rafailidis PI, Tansarli GS. Antibiotic
Table 2
Class Spectrum Available preparations Route of Effective against Not effective 
administration against
Carbapenem Broad Meroponem/imepenem Intravenous GPC, GNB, MRSA, VRE.
/ ertapenem anaerobes Ertapenem ineffective
against pseudomonas
B lactamase Broad Piperacillin – tazobactam Intravenous GPC, GNB, MRSA, VRE
inhibitor anaerobes.
3rd gen
Cephalosporin Broad Cefaperazone- sulbactam Intravenous GPC, GNB, MRSA, VRE
anaerobes.
1st gen
cephalosporin Narrow Cefazolin, Cephradine Intravenous Strept MRSA,VRE,anaerobes
3rd gen
Cephalosporin Broad Ceftriaxone Intravenous Strept, GNR MRSA,VRE,anaerobes
3rd gen
Cephalospor Broad Ceftazidime Intravenous GNR, esp pseudom MRSA,VRE,anaerobes
Glycopeptide Narrow Vancomycin Intravenous MRSA,enterococcus GNR, anaerobes
Aminoglycoside Narrow Amikacin, Tobramycin, Intravenous GNRStrept and Entero,, anaerobes
Gentamicin
B lactamase
inhibitor Broad Amoxicillin- clavulanate Intravenous GPC, some GNR, E coli, enterobacteriacae
and oral anaerobes
FluoroquinolonesBroad Levofloxacin Intravenous GPC,atypical resp Anaerobes
and oral pathogens
Macrolides Narrow Azithromycin, Oral Atypical resp GNR, anaerobes
clarithromycin pathogens
Lincosamide Narrow Clindamycin Intravenous Strep, Staph GNR
and oral (MSSA)
GPC= gram positive cocci, GNR= gram negative rods
MSSA= methicillin sensitive Staph aureus
MRSA= methicillin resistant Staph aureus
Submitted by : Dr. Naseem Salahuddin
Endorsed by : Members of Medical Microbiologists and
Infectious Disease Society of Pakistan
(MMIDSP)
796 . Infectious Diseases Journal of Pakistan
treatment of infections due to carbapenem-resistant Enterobacteriaceae:
systematic evaluation of the available evidence. Antimicrob Agents.
Chemother. 2014;58(2):654-63
18. Falagas ME, Tansarli GS, Karageorgopoulos DE, Vardakas KZ. Deaths
attributable to carbapenem-resistant Enterobacteriaceae infections. Emerg
Infect Dis. 2014 Jul;20(7):1170-5.
19. Kalam K, Qamar F,Kumar S,Ali S,Baqi S. Risk factors for carbapenem
resistant bacteraemia and mortality due to gram negative bacteraemia in
a developing country. J Pak Med Assoc. Vol. 64, No. 5, May 2014. 530-536
20. Doan LA Peripheral versus central venous delivery of medications during
CPR Ann Emerg Med 1984 Sep; 13(9 Pt 2): 784-6
21. Emerman CL, Pinchak AC, Hancock D, Hagen JF. Effect of injection site
in circulation times during cardiac arrest. Crit Care Med 1988 Nov;
16(11):1138-1141
22. Raghunathan K, Murray PT, Beattie WS, Lobo DN, Myburgh J, Sladen
R, et al. Choice of fluid in acute illness: what should be given? An
international consensus. British journal of anaesthesia. 2014;113(5):772-83.
23. Hoste EA, Maitland K, Brudney CS, et al for the ADQI XII Investigators
Group. Four phases of intravenous fluid therapy: a conceptual model.
British Journal of Anaesthesia 2014; 113(5): 740-747
24. Vincent JL, Weil MH. Fluid challenge revisited. Crit Care Med 2006; 34:
1333-1337
25. De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C,
et al. Comparison of dopamine and norepinephrine in the treatment of
shock. New England Journal of Medicine. 2010;362(9):779-89.
26. Thiel SW, Asghar MF, Micek ST, Reichley RM, Doherty JA, Kollef MH.
Hospital-wide impact of a standardized order set for the management of
bacteremic severe sepsis*. Critical care medicine. 2009;37(3):819-24.
27. Bundle Definition: http://www.ihi.org/topics/bundles/Pages/default.aspx
Last accessed Feb 19, 2015
28. ACCP-SCCM Consensus Conference; definition of sepsis and multiple
organ failure and guidelines for the use of innovative therapies in sepsis
Crit Care Med 1992; 20:864-874
